Journal articleCancer Lett2021
CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinoma.
- Journal
- Cancer Lett
- Published
- 30 November 2020
- Citations
- 38
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 5
- Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro K23CA148964↗
- Cancer Prevention and Control Program P30CA006973↗
- Core 2: Biospecimen/Pathology Core P50CA062924↗
- Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer R01CA169702↗
- Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial R01CA197296↗